TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptors

Abstract This study suggests a modified model of TNFR1-induced complex I-mediated NFκB signaling. Evaluation of a panel of five tumor cell lines (HCT116-PIK3CAmut, SK-MEL-23, HeLa-RIPK3, HT29, D10) with TRAF2 knockout revealed in two cell lines (HT29, HeLa-RIPK3) a sensitizing effect for death recep...

Full description

Saved in:
Bibliographic Details
Main Authors: Jennifer Wagner, David Vredevoogd, Xin Yu, Dong Lu, Daniel S. Peeper, Heike M. Hermanns, Jin Wang, Harald Wajant, Daniela Siegmund
Format: Article
Language:English
Published: Nature Publishing Group 2025-01-01
Series:Cell Death and Disease
Online Access:https://doi.org/10.1038/s41419-024-07325-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832585377803665408
author Jennifer Wagner
David Vredevoogd
Xin Yu
Dong Lu
Daniel S. Peeper
Heike M. Hermanns
Jin Wang
Harald Wajant
Daniela Siegmund
author_facet Jennifer Wagner
David Vredevoogd
Xin Yu
Dong Lu
Daniel S. Peeper
Heike M. Hermanns
Jin Wang
Harald Wajant
Daniela Siegmund
author_sort Jennifer Wagner
collection DOAJ
description Abstract This study suggests a modified model of TNFR1-induced complex I-mediated NFκB signaling. Evaluation of a panel of five tumor cell lines (HCT116-PIK3CAmut, SK-MEL-23, HeLa-RIPK3, HT29, D10) with TRAF2 knockout revealed in two cell lines (HT29, HeLa-RIPK3) a sensitizing effect for death receptor-induced necroptosis and in one cell line (D10) a mild sensitization for TNFR1-induced apoptosis. TRAF2 deficiency inhibited death receptor-induced classical NFκB-mediated production of IL-8 only in a subset of cell lines and only partly. TRAF5, furthermore, failed to improve DR-induced NFκB signaling in HCT116-PIK3CAmut and HCT116-PIK3CAmut-TRAF2KO cells. These findings argue for a non-obligatory role of TRAF2 in death receptor-induced classical NFκB signaling. Similar as in TRAF2-deficient cells, TNF- and CD95L-induced NFκB signaling was found to be only poorly affected in RIPK1KO cells and in cells treated with the RIPK1-specific PROTAC LD4172. Intriguingly, however, death receptor-induced NFκB signaling was completely inhibited in HCT116-PIK3CAmut cells double deficient for TRAF2 and RIPK1 and in TRAF2-deficient cells treated with LD4172. Moreover, with exception of recruitment of TRADD, acting upstream to TRAF2 and parallel to RIPK1, TNFR1 signaling complex formation was abrogated in TRAF2-RIPK1 DKO cells. Based on our findings, two distinguishable types of TNFR1-interacting complexes promote TNF-induced NFκB signaling: First, a TRADD-TRAF2/cIAP utilizing complex Ia which becomes evident in RIPK1-deficient cells. Second, a non-modified RIPK1 utilizing complex Ib which acts in TRADD- or TRAF2-deficient cells. Complex Ia and Ib may furthermore interact and cooperate to ubiquitinate RIPK1 resulting in a modified complex Ia/b preventing complex Ia and Ib to convert to the established TNFR1-induced cytotoxic complexes IIa and IIb.
format Article
id doaj-art-b17dfd3c4e3d4eab8954cf842c545597
institution Kabale University
issn 2041-4889
language English
publishDate 2025-01-01
publisher Nature Publishing Group
record_format Article
series Cell Death and Disease
spelling doaj-art-b17dfd3c4e3d4eab8954cf842c5455972025-01-26T12:54:40ZengNature Publishing GroupCell Death and Disease2041-48892025-01-0116111410.1038/s41419-024-07325-xTRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptorsJennifer Wagner0David Vredevoogd1Xin Yu2Dong Lu3Daniel S. Peeper4Heike M. Hermanns5Jin Wang6Harald Wajant7Daniela Siegmund8Division of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Auvera Haus Grombühlstraße 12Division of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121The Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of MedicineThe Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of MedicineDivision of Molecular Oncology and Immunology, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121Division of Hepatology, Department of Internal Medicine II, University Hospital Würzburg, Auvera Haus Grombühlstraße 12The Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of MedicineDivision of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Auvera Haus Grombühlstraße 12Division of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Auvera Haus Grombühlstraße 12Abstract This study suggests a modified model of TNFR1-induced complex I-mediated NFκB signaling. Evaluation of a panel of five tumor cell lines (HCT116-PIK3CAmut, SK-MEL-23, HeLa-RIPK3, HT29, D10) with TRAF2 knockout revealed in two cell lines (HT29, HeLa-RIPK3) a sensitizing effect for death receptor-induced necroptosis and in one cell line (D10) a mild sensitization for TNFR1-induced apoptosis. TRAF2 deficiency inhibited death receptor-induced classical NFκB-mediated production of IL-8 only in a subset of cell lines and only partly. TRAF5, furthermore, failed to improve DR-induced NFκB signaling in HCT116-PIK3CAmut and HCT116-PIK3CAmut-TRAF2KO cells. These findings argue for a non-obligatory role of TRAF2 in death receptor-induced classical NFκB signaling. Similar as in TRAF2-deficient cells, TNF- and CD95L-induced NFκB signaling was found to be only poorly affected in RIPK1KO cells and in cells treated with the RIPK1-specific PROTAC LD4172. Intriguingly, however, death receptor-induced NFκB signaling was completely inhibited in HCT116-PIK3CAmut cells double deficient for TRAF2 and RIPK1 and in TRAF2-deficient cells treated with LD4172. Moreover, with exception of recruitment of TRADD, acting upstream to TRAF2 and parallel to RIPK1, TNFR1 signaling complex formation was abrogated in TRAF2-RIPK1 DKO cells. Based on our findings, two distinguishable types of TNFR1-interacting complexes promote TNF-induced NFκB signaling: First, a TRADD-TRAF2/cIAP utilizing complex Ia which becomes evident in RIPK1-deficient cells. Second, a non-modified RIPK1 utilizing complex Ib which acts in TRADD- or TRAF2-deficient cells. Complex Ia and Ib may furthermore interact and cooperate to ubiquitinate RIPK1 resulting in a modified complex Ia/b preventing complex Ia and Ib to convert to the established TNFR1-induced cytotoxic complexes IIa and IIb.https://doi.org/10.1038/s41419-024-07325-x
spellingShingle Jennifer Wagner
David Vredevoogd
Xin Yu
Dong Lu
Daniel S. Peeper
Heike M. Hermanns
Jin Wang
Harald Wajant
Daniela Siegmund
TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptors
Cell Death and Disease
title TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptors
title_full TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptors
title_fullStr TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptors
title_full_unstemmed TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptors
title_short TRAF2 and RIPK1 redundantly mediate classical NFκB signaling by TNFR1 and CD95-type death receptors
title_sort traf2 and ripk1 redundantly mediate classical nfκb signaling by tnfr1 and cd95 type death receptors
url https://doi.org/10.1038/s41419-024-07325-x
work_keys_str_mv AT jenniferwagner traf2andripk1redundantlymediateclassicalnfkbsignalingbytnfr1andcd95typedeathreceptors
AT davidvredevoogd traf2andripk1redundantlymediateclassicalnfkbsignalingbytnfr1andcd95typedeathreceptors
AT xinyu traf2andripk1redundantlymediateclassicalnfkbsignalingbytnfr1andcd95typedeathreceptors
AT donglu traf2andripk1redundantlymediateclassicalnfkbsignalingbytnfr1andcd95typedeathreceptors
AT danielspeeper traf2andripk1redundantlymediateclassicalnfkbsignalingbytnfr1andcd95typedeathreceptors
AT heikemhermanns traf2andripk1redundantlymediateclassicalnfkbsignalingbytnfr1andcd95typedeathreceptors
AT jinwang traf2andripk1redundantlymediateclassicalnfkbsignalingbytnfr1andcd95typedeathreceptors
AT haraldwajant traf2andripk1redundantlymediateclassicalnfkbsignalingbytnfr1andcd95typedeathreceptors
AT danielasiegmund traf2andripk1redundantlymediateclassicalnfkbsignalingbytnfr1andcd95typedeathreceptors